Project Grant HT9425261E123
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- Federal Grant Award Summary The Ohio State University received a $1,574,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded on June 15, 2025, with a completion date of June 14, 2028. The project, titled "SLIT2 as a Novel Approach for Targeting Metastatic Breast Cancer," is conducted through the university's Office of Sponsored Programs in Columbus, Ohio. This award supports advanced biomedical research aimed...
- Federal Grant Award Summary The Ohio State University's Office of Sponsored Programs received a $320,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2027. The award supports research to develop a gammaherpesvirus-dependent mouse model of multiple sclerosis (MS) designed to investigate how Epstein-Barr virus (EBV)-encoded genes reprogram and create pathogenic B...
- Federal Project Grant Award Summary The Ohio State University received a $2,976,672 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2029. The award funds research examining the efficacy of short-term intensive Post-Traumatic Stress Disorder (PTSD) treatment on psychological and cognitive impairment symptoms. Research will be conducted at the university's Columbus, Ohio...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Ohio State University a $5.01 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. The award supports development and implementation of the Core Competency Model-Military Version (CCM-MV), an evidence-based virtual suicide prevention training platform for military healthcare providers. The project delivers a comprehensive...
- Federal Grant Award Summary The Cleveland Clinic Foundation received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded May 1, 2026, with a completion date of April 30, 2030. The award funds research focused on deciphering the role of the gut and tumor microbiome on ovarian cancer progression and resistance to chemotherapy. Research will be conducted at the Cleveland Clinic Health System facility in...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
- Federal Grant Award Summary Oregon State University received a $757,521 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2028. The research project, titled "Impact of the Gut Microbiota on Gut Sensory Neurocircuits in Autism Spectrum Disorder," investigates the relationship between gut microbiota composition and sensory neural circuits implicated in autism spectrum...
- This Project Grant award, valued at $1,317,976.00 and effective July 1, 2025, was provided by the Defense Health Agency to The Ohio State University to conduct research targeting the RAL G proteins to treat triple-negative breast cancer. The research will be performed at The Ohio State University in Columbus, Ohio, and is expected to be completed by June 30, 2028. The project is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical...
- The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
- The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...